Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1919-1929

  Bellusci, Mariangela ^a   La Barbera, Aurelio ^a   Padella, Franco ^a   Mancuso, Mariateresa ^a   Pasquo, Alessandra ^a   Grollino, Maria Giuseppa ^a   Leter, Giorgio ^a   Nardi, Elisa ^a   Cremisini, Carlo ^a   Giardullo, Paola ^b   Pacchierotti, Francesca ^a  

^a ENEA C R CASACCIA   (Italy)

^b Technical Unit for Radiation Biology and Human Health Prevention and Recovery Agenzia Nazionale per le Nuove Tecnologie L'Energia e lo Sviluppo Economico Sostenibile ^*  (Italy)

Author keywords

Biodistribution; Biosafety; Ferrofluid; ICP MS; Prussian blue staining

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MANGANESE IRON OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; COLLOID; CONTRAST MEDIUM; MAGNETITE NANOPARTICLE; MANGANESE; SOLUTION AND SOLUBILITY;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOSAFETY; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIGHT SCATTERING; LIVER; MASS SPECTROMETRY; MECHANOTRANSDUCTION; MOUSE; NANOBIOTECHNOLOGY; NONHUMAN; SPLEEN; 3T3 CELL LINE; ANIMAL; ANTIBODY SPECIFICITY; CELL SURVIVAL; CHEMISTRY; COLLOID; DIFFUSION; DOSE RESPONSE; DRUG EFFECTS; DRUG FORMULATION; FEMALE; LD50; MATERIALS TESTING; MECHANICAL STRESS; PROCEDURES; SOLUTION AND SOLUBILITY; SURVIVAL RATE; SYNTHESIS; TISSUE DISTRIBUTION; TOXICITY;

ANIMALS; BALB 3T3 CELLS; CELL SURVIVAL; COLLOIDS; CONTRAST MEDIA; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; FEMALE; LETHAL DOSE 50; MAGNETITE NANOPARTICLES; MANGANESE; MATERIALS TESTING; MICE; ORGAN SPECIFICITY; SOLUTIONS; STRESS, MECHANICAL; SURVIVAL RATE; TISSUE DISTRIBUTION;

EID: 84899154134     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S56394     Document Type: Article

References (35)

1. Eifler AC, Thaxton CS. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. Methods Mol Biol. 2011;726: 325-338.
2. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012;338(6109):903-910.
3. Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev. 2014;43(3):744-764.
4. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg. 2011;1(1): 35-40.
5. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics and therapy. Acc Chem Res. 2011;44(10):842-852.
6. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol. 2003;13(6): 1266-1276.
7. Pankhurst A, Thanh NK, Jones SK, Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2009;42(22): 224001.
8. Yang HW, Hua MY, Liu HL, Huang CY, Wei KC. Potential of magnetic nanoparticles for targeted drug delivery. Nanotechnol Sci Appl. 2012;5: 76-86.
9. Ling D, Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small. 2013;9(9-10):1450-1466.
10. Adolphi NL, Butler KS, Lovato DM, et al. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol Imaging. 2012;7(3):308-319.
11. Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2008;24(6):467-474.
12. Thomas R, Park IK, Jeong YY. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int J Mol Sci. 2013;14(8): 15910-15930.
13. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem Commun (Camb). 2003;21(8):927-933.
14. Soenen SJ, De Cuyper M. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine (Lond). 2010;5(8):1261-1275.
15. Lee JH, Huh YM, Jun YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13(1): 95-99.
16. Yang H, Zhang C, Shi X, et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. Biomaterials. 2010;31(13):3667-3673.
17. Pelaz B, Charron G, Pfeiffer C, et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small. 2013;9(9-10):1573-1584.
18. Yang SH, Heo D, Park J, et al. Role of surface charge in cytotoxicity of charged manganese ferrite nanoparticles towards macrophages. Nanotechnology. 2012;23(50):505702.
19. Bellusci M, Aliotta C, Fiorani D, et al. Manganese iron oxide superparamagnetic powder by mechanochemical processing. Nanoparticles functionalization and dispersion in a nanofluid. J Nanopart Res. 2012;14(6):904-914.
20. Mazzotti F, Sabbioni E, Ghiani M, Cocco B, Ceccatelli R, Fortaner S. In vitro assessment of cytotoxicity and carcinogenic potential of chemicals: Evaluation of the cytotoxicity induced by 58 metal compounds in the BALB/3T3 cell line. Altern Lab Anim. 2001;29(5):601-611.
21. Wataha JC, Hanks CT, Sun Z. Effect of cell line on in vitro metal ion cytotoxicity. Dent Mater. 1994;10(3):156-161.
22. Ponti J, Colognato R, Rauscher H, et al. Colony forming efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol Lett. 2010;197(1):29-37.
23. Suzuki H, Toyooka T, Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ Sci Technol. 2007;41(8): 3018-3024.
24. Toduka Y, Toyooka T, Ibuki Y. Flow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence-correlation with genotoxicity. Environ Sci Technol. 2012;46(14):7629-7636.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
26. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315-2319.
27. Stone V, Johnston H, Schins RP. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol. 2009;39(7):613-626.
28. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticles toxicity in a human cell line. Toxicol Appl Pharmacol. 2009;234(2):222-235.
29. Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Fukagawa NK, Mossman BT. Assessing nanotoxicity in cells in vitro. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(3):219-231.
30. Paek HJ, Lee YJ, Chung HE, et al. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale. 2013;5(23):11416-11427.
31. Chen J, Wang H, Long W, et al. Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int J Nanomedicine. 2013;8:2409-2419.
32. Uboldi C, Giudetti G, Broggi F, Gilliland D, Ponti J, Rossi F. Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. Mutat Res. 2012;745(1-2):11-20.
33. Sabbioni E, Fortaner S, Farina M, et al. Interaction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts. Nanotoxicology. 2014;8(1):88-99.
34. Ceriotti L, Kob A, Drechsler S, et al. Online monitoring of BALB/3T3 metabolism and adhesion with multiparametric chip-based system. Anal Biochem. 2007;371(1):92-104.
35. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm. 2008;5(2):316-327.